Hartl said that in Europe, several drug firms are set tosubmit clinical trial data in the next few weeks, with GlaxoSmithKline likely to be among the first.
Boston Scientific released positive clinical trial results last month and is in the process of preparing tosubmit application for approval for its device in Europe.
In order to perform a field trial with a regulated article, a researcher must apply to USDA for a permit and submit a huge amount of data, which makes genetically engineered plants extraordinarily expensive to develop and test.